News Releases

RSS Feeds

Quest Diagnostics to Speak at Goldman Sachs 23rd Annual Global Healthcare Conference
PRNewswire-FirstCall
TETERBORO, N.J.

Quest Diagnostics Incorporated , the nation's leading provider of diagnostic testing, information and services, announced that Robert A. Hagemann, Vice President and Chief Financial Officer, is scheduled to speak at the Goldman Sachs 23rd Annual Global Healthcare Conference on Tuesday, June 11, 2002, at the Ritz-Carlton Laguna Niguel in Dana Point, California. The Quest Diagnostics presentation is scheduled to begin at 7:40 a.m. Pacific Time.

The conference is being webcast live and can be accessed on the Internet using RealPlayer only at: https://www.gs.com/ir/conf. Enter the user name conference/confd and the password healthcare in lowercase letters, as they are case sensitive. You may also access the live webcast at the Quest Diagnostics website at: http://www.questdiagnostics.com/. In addition, a replay of the webcast will be available until August 13, 2002, following the conference.

Quest Diagnostics Incorporated is the nation's leading provider of diagnostic testing, information and services, providing insights that enable physicians, hospitals, managed care organizations and other healthcare professionals to make decisions to improve health. The company offers the broadest access to diagnostic laboratory services through its national network of laboratories and patient service centers. Quest Diagnostics is the leading provider of esoteric testing, including gene-based medical testing, and empowers healthcare organizations and clinicians with state-of-the-art connectivity solutions that improve practice management. Additional company information can be found on the Internet at: http://www.questdiagnostics.com/ .

The statements in this press release which are not historical facts or information may be forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause the outcome to be materially different. Certain of these risks and uncertainties are listed in the Quest Diagnostics Incorporated 2001 Form 10-K and subsequent filings.

MAKE YOUR OPINION COUNT - Click Here
http://tbutton.prnewswire.com/prn/11690X42063847

SOURCE: Quest Diagnostics Incorporated

CONTACT: Investors - Laure Park, +1-201-393-5030, Media - Gary Samuels,
+1-201-393-5700, both for Quest Diagnostics Incorporated

Web site: http://www.questdiagnostics.com/